Consistently, Chen and his colleagues demonstrated that the CRC cells with a high expression of Sox2 had stem-like features including a higher proportion of CD133+ expression, higher sphere formation efficacy, poorer differentiation, and greater migratory and invasive activity. The gene discussed is SOX2; the disease is colorectal carcinoma.